1. Home
  2. GUTS vs AXTI Comparison

GUTS vs AXTI Comparison

Compare GUTS & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GUTS
  • AXTI
  • Stock Information
  • Founded
  • GUTS 2010
  • AXTI 1986
  • Country
  • GUTS United States
  • AXTI United States
  • Employees
  • GUTS N/A
  • AXTI N/A
  • Industry
  • GUTS
  • AXTI Semiconductors
  • Sector
  • GUTS
  • AXTI Technology
  • Exchange
  • GUTS NYSE
  • AXTI Nasdaq
  • Market Cap
  • GUTS 110.1M
  • AXTI 93.9M
  • IPO Year
  • GUTS 2024
  • AXTI 1998
  • Fundamental
  • Price
  • GUTS $1.80
  • AXTI $2.26
  • Analyst Decision
  • GUTS Buy
  • AXTI Strong Buy
  • Analyst Count
  • GUTS 2
  • AXTI 5
  • Target Price
  • GUTS $18.00
  • AXTI $5.30
  • AVG Volume (30 Days)
  • GUTS 382.2K
  • AXTI 282.2K
  • Earning Date
  • GUTS 02-02-2025
  • AXTI 02-20-2025
  • Dividend Yield
  • GUTS N/A
  • AXTI N/A
  • EPS Growth
  • GUTS N/A
  • AXTI N/A
  • EPS
  • GUTS N/A
  • AXTI N/A
  • Revenue
  • GUTS $97,000.00
  • AXTI $94,685,000.00
  • Revenue This Year
  • GUTS N/A
  • AXTI $32.13
  • Revenue Next Year
  • GUTS N/A
  • AXTI $12.84
  • P/E Ratio
  • GUTS N/A
  • AXTI N/A
  • Revenue Growth
  • GUTS N/A
  • AXTI 15.24
  • 52 Week Low
  • GUTS $1.74
  • AXTI $1.73
  • 52 Week High
  • GUTS $14.50
  • AXTI $5.64
  • Technical
  • Relative Strength Index (RSI)
  • GUTS 40.50
  • AXTI 53.83
  • Support Level
  • GUTS $1.91
  • AXTI $1.99
  • Resistance Level
  • GUTS $2.10
  • AXTI $2.28
  • Average True Range (ATR)
  • GUTS 0.16
  • AXTI 0.13
  • MACD
  • GUTS -0.01
  • AXTI -0.00
  • Stochastic Oscillator
  • GUTS 6.12
  • AXTI 62.79

About GUTS FRACTYL HEALTH INC

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

Share on Social Networks: